3 research outputs found
Cost-Effectiveness of Testing for Breast Cancer Susceptibility Genes
- Author
- Aetna
- Alissa Huston
- Anderson
- Arias
- Arozullah
- BlueCross BlueShield of North Carolina
- Bradley
- Brenner
- Briggs
- Cappelli
- Centers for Medicare and Medicaid Services
- Conner-Spady
- Dowdy
- Fireman
- Foster
- Frank
- Geiger
- Gold
- Grann
- Grann
- James
- Jansen
- Katia Noyes
- Keenan-Miller
- King
- Kinney
- Lawrence
- Lerman
- Lubitz
- Margaret L. Holland
- Mouchawar
- Myriad Genetic Laboratories
- Nelson
- Palma
- PDR Staff
- Phillips
- Polsky
- Regence
- Ries
- Riley
- Romano
- Sardanelli
- Saslow
- Scheuer
- Schmeler
- Sullivan
- Surveillance Epidemiology, and End Results (SEER) Program
- Texas Medicaid & Healthcare Partnership
- The CEA Registry Tufts-New England Medical Center
- Tufts Health Plan
- United Healthcare Oxford
- US Department of Health and Human Services
- van Oostrom
- van Roosmalen
- Wainberg
- Walsh
- Watson
- Wellmark BlueCross BlueShield
- Whittemore
- Publication venue
- 'Wiley'
- Publication date
- Field of study
No full textProposal of Polish Guidelines for Conducting Financial Analysis and Their Comparison to Existing Guidance on Budget Impact in Other Countries
- Author
- Alban
- Belgian Society for Pharmacoepidemiology
- Canadian Coordinating Office for Health Technology Assessment (CCOHTA)
- Commonwealth Department of Human Services and Health
- Department of Health
- Ewa Orlewska
- Finnish Ministry of Social Affairs and Health
- Garattini
- Health-Care Economics Consensus Group
- Kanavos
- National Institute for Clinical Excellence
- Norwegian Medicines Control Authority
- Ontario Ministry of Health
- Orlewska
- Orlewska
- Orlewska
- Piotr Mierzejewski
- Portuguese Pharmacy and Medicines Institute
- Regence BlueShield
- Riteco
- Rovira
- Swiss Federal Office Office of Social Security
- Szende
- Task Force on the Economic Evaluation of Pharmaceuticals
- Toffler
- Trueman
- Publication venue
- 'Wiley'
- Publication date
- Field of study
No full textHealth Economic Guidelines—Similarities, Differences and Some Implications
- Author
- Alban
- Anis
- Anonymous
- Anonymous
- Australian Commonwealth Department of Health Housing Community Services
- Australian Commonwealth Department of Health Housing Community Services
- Belgian Society for Pharmacoepidemiology
- Bundesamt fĂĽr Sozialversicherung
- Canadian Coordinating Office for Health Technology Assessment
- Collège des Economistes de la Santé
- DeVries
- Drummond
- Drummond
- Drummond
- Drummond
- Finish Ministry of Social Affairs and Health
- Fredrik Andersson
- Fredrik Berggren
- Garattini
- Genduso
- General Directorate of Services and Evaluation of Health Technologies and the General Directorate of Insurance and Health Planning of the Ministry of Health and Consumption
- Gold
- Government/Pharmaceutical Industry Working Party
- Graf vd Shulenberg J-M
- Gricar
- Hill
- Hutton
- Jacobs
- Jonas Hjelmgren
- Langley
- Luce
- Mather
- Mullins
- National Center for Pharmacoeconomics in Ireland
- National Institute for Clinical Excellence
- Norwegian Medicines Control Authority
- Ontario Ministry of Health
- Pharmaceutical Management Agency Limited
- Pharmaceutical Research and Manufacturers of America
- Regence BlueShield
- Rennie
- Rovira
- Siegel
- Task Force on Principles for Economic Analysis of Health Care Technology
- The Portuguese Pharmacy and Medicines Institute
- US Food Drug Administration
- Ziekenfondraad
- Publication venue
- 'Wiley'
- Publication date
- Field of study
No full text
